Rebamipide: evidence base for use in gastroenterology

Rebamipide: evidence base for use in gastroenterology

Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and larg...

Full description

Bibliographic Details
Main Authors:	D. N. Andreev, I. V. Maev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2020-12-01
Series:	Терапевтический архив
Subjects:	rebamipide gastroesophageal reflux disease corrosive esophagitis functional dyspepsia chronic gastritis peptic ulcer disease helicobacter pylori nsaid gastropathy nsaid enteropathy ulcerative colitis
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/60263/43430

Similar Items

CLINICAL AND PHARMACOLOGICAL CHARACTERISTICS OF THE USE OF REBAMIPIDE IN DISEASES OF THE GASTROINTESTINAL TRACT LITERATURE REVIEW
by: V. I. SIMANENKOV, et al.
Published: (2016-12-01)

Rebamipide: New opportunities of gastroenteroprotection
by: V I Simanenkov, et al.
Published: (2015-12-01)

Efficacy and Safety of Rebamipide in Prevention of NSAID-Gastropathy
by: Serhiy Tkach, et al.
Published: (2017-03-01)

Evaluation of efficacy and safety of rebamipide use in the triple therapy for Helicobacter pylori eradication: a pilot study
by: D. T. Dicheva, et al.
Published: (2018-04-01)

Pharmacological and clinical feature of rebamipide: new therapeutic targets
by: M. Yu. Zvyaglova, et al.
Published: (2020-02-01)

Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates
by: Della Libera E., et al.
Published: (2001-01-01)

Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia
by: Belete Assefa, et al.
Published: (2022-04-01)

Review – H. pylori & non-malignant diseases
by: L. Coelho, et al.
Published: (2023-10-01)

Prospective Survey for the Etiology and Outcome of Peptic Ulcer Bleeding: A Community Based Study in Southern Taiwan
by: Chi-Yang Chang, et al.
Published: (2011-04-01)

Rebamipide using in gastroesophageal reflux disease treatment
by: V. T. Ivashkin, et al.
Published: (2020-04-01)

The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract
by: E P Yakovenko, et al.
Published: (2016-04-01)

The Effectiveness of Rebamipide in Combined Treatment of Patients with Peptic Ulcer of the Stomach and Duodenum
by: Demydova A., et al.
Published: (2017-03-01)

Clinical presentation and surgical management of perforated peptic ulcer in a tertiary hospital in Mogadishu, Somalia: a 5-year retrospective study
by: Abdihamid Mohamed Ali, et al.
Published: (2022-05-01)

The peculiarities of pathogenesis of NSAID-induced gastrointestinal injuries and current prevention strategies
by: Anatol Święcicki, et al.
Published: (2014-07-01)

Modern opportunities for treatment and prevention of NSAID-induced enteropathies
by: I. A. Viktorova, et al.
Published: (2020-05-01)

NSAID-induced damage to the gastrointestinal tract: new opportunities for the prevention of gastro- and enteropathies
by: V. N. Drozdov, et al.
Published: (2020-01-01)

Dyspepsia: literature review and evidence for management in primary care
by: M. Torlutter, et al.
Published: (2018-07-01)

A question about dyspeptic patients analyzed using psychometric scores
by: Rinaldo Pellicano, et al.

Peptic ulcer: the current state of the problem
by: I. V. Maev, et al.
Published: (2022-04-01)

Importance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease
by: Dajani A, et al.
Published: (2006-01-01)

Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers
by: Yoon Jin Choi
Published: (2022-12-01)

Helicobacter pylori y dispepsia, un problema de salud comunitario
by: Miguel González-Carbajal Pascual, et al.
Published: (2002-06-01)

The improvement of treatment efficacy of gastropathy associated with the use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-negative patients with osteoarthritis
by: Antonenko Antonina V., et al.
Published: (2014-12-01)

Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01)

ESOPHAGEAL REFLUX DISEASE, PEPTIC ULCER AND HELICOBACTER PYLORI INFECTION – A PROSPECTIVE, CONTROLLED STUDY
by: Pavel Skok, et al.
Published: (2003-02-01)

The Efficacy of Eradication of Helicobacter pylori Infection in Primary Prevention of NSAID-induced Gastropathy
by: S.M. Tkach, et al.
Published: (2015-09-01)

Histopathological Analysis of Gastric Biopsies using Updated Sydney System
by: Muhammad Zubair, et al.
Published: (2022-12-01)

Zoonotic potential of Helicobacter spp.
by: Irena Mladenova-Hristova, et al.
Published: (2017-06-01)

Perforated duodenal ulcer: Emerging pattern
by: Murtaza Ali Asger Calcuttawala, et al.
Published: (2014-01-01)

Trends in peptic ulcer disease and the identification of Helicobacter Pylori as a causative organism: Population-based estimates from the US nationwide inpatient sample
by: Bronislava Bashinskaya, et al.
Published: (2011-01-01)

Dyspepsia: A Great Diagnosis Challenge
by: Carlos E. Pinzón Flórez, MD, et al.
Published: (2008-04-01)

Do glucocorticoids affect the development of ulcers and erosions of the upper gastrointestinal tract in patients taking NSAIDs?
by: A E Karateev, et al.
Published: (2018-05-01)

Helicobacter pylori among patients with symptoms of gastroduodenal ulcer disease in rural Uganda
by: Lawrence Tsongo, et al.
Published: (2015-11-01)

New Trends and Advances in Non-Variceal Gastrointestinal Bleeding—Series II
by: Pablo Cañamares-Orbís, et al.
Published: (2021-07-01)

Features of the blood cytokine profile in gastroesophageal reflux disease in schoolchildren with gastritis and family history of peptic ulcer
by: T. V. Polivanova, et al.
Published: (2023-06-01)

Are endoscopic findings predictive for the presence of H. pylori infection? What about indirect histologic findings?
by: Mohammad Hasan Emami, et al.
Published: (2007-06-01)

Helicobacter pylori infection has no impact on manometric and pH-metric findings in adolescents and young adults with gastroesophageal reflux and antral gastritis: eradication results to no significant clinical improvement
by: Ioannis Xinias, et al.
Published: (2013-02-01)

A review on anti-peptic ulcer activities of medicinal plants used in the formulation of Enterica, Dyspepsia and NPK 500 capsules
by: Doris Kumadoh, et al.
Published: (2021-12-01)

Antiulcerogenic activity of Anogeissus pendula hydroalcoholic extract on pylorus ligated induced gastric ulcers in Albino Wistar rats
by: Priyanka Danai, et al.
Published: (2021-11-01)

Diagnosis and Management of Gastroenteropathy Asssociated to Non-steroidal Anti-Inflammatory Drugs
by: Stella Ilone, et al.
Published: (2016-09-01)